Isthmus Partners, LLC Haemonetics Corp Transaction History
Isthmus Partners, LLC
- $800 Million
- Q4 2024
A detailed history of Isthmus Partners, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Isthmus Partners, LLC holds 40,220 shares of HAE stock, worth $2.56 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
40,220
Previous 39,770
1.13%
Holding current value
$2.56 Million
Previous $3.2 Million
1.75%
% of portfolio
0.39%
Previous 0.39%
Shares
5 transactions
Others Institutions Holding HAE
# of Institutions
349Shares Held
55.7MCall Options Held
600KPut Options Held
474K-
Black Rock Inc. New York, NY5.96MShares$379 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.18MShares$330 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.42MShares$281 Million0.29% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.24MShares$270 Million0.07% of portfolio
-
Wellington Management Group LLP Boston, MA3.94MShares$251 Million0.06% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.27B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...